Author:
Maubert Elise,Weber Valérie,Voissière Aurélien,Gérard Yvain,Dedieu Véronique,Degoul Françoise,Chezal Jean-Michel,Chautard Emmanuel,Miot-Noirault Elisabeth
Funder
This work was supported by the PRT-k Translational Cancer Research INCa-DGOS program (D-TECT project).
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference18 articles.
1. Aigner T, Oliveira AM, Nascimento AG (2004) Extraskeletal myxoid chondrosarcomas do not show a chondrocytic phenotype. Mod Pathol 17(2):214–221
2. Sasbou Y, Rhanim A, Mhammdi Y, Nkaoui M, El Bardouni A, Berrada MS et al (2015) Chondrosarcome myxoïde extra-osseux: à propos d’un cas et revue de la littérature. Pan Afr Med J 20:360
3. Davis EJ, Wu Y-M, Robinson D, Schuetze SM, Baker LH, Athanikar J, Cao X, Kunju LP, Chinnaiyan AM, Chugh R (2017) Next generation sequencing of extraskeletal myxoid chondrosarcoma. Oncotarget 8(13):21770–21777
4. Elsayed AG, Al-Qawasmi L, Katz H, Lebowicz Y (2018) Extraskeletal Chondrosarcoma: long-term follow-up of a patient with metastatic disease. Cureus 10(5):e2709
5. Drilon AD, Popat S, Bhuchar G, D’Adamo DR, Keohan ML, Fisher C et al (2008) Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy. Cancer 113(12):3364–3371